Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Mauricio Herrera

Sports Medicine Miami, FL Medical Doctor

NPI 1306844303 CMS profile 1225094

11801 Sw 90Th St, Suite 201, Miami, FL 33186

Open in the dashboard

General payments

$41,135

270 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Mauricio Herrera of Miami, FL is reported in the CMS Open Payments database as having received $41,135 across 270 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 83rd percentile of Sports Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $8,437 39
2024 General $3,301 43
2023 General $10,015 39
2022 General $1,671 39
2021 General $2,923 18
2020 General $1,927 25
2019 General $12,861 67

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Mauricio Herrera
  • Sports Medicine median
  • Middle half of Sports Medicine
  • National median

In program year 2025, general payments to Mauricio Herrera were reported at $8,437. Among 2,404 Sports Medicine profiles paid that year, the median was $664 and the middle half received between $172 and $3,055.

Show as a table
Year Mauricio Herrera Sports Medicine median Middle half National median
2019 $12,861 $1,176 $199–$4,249 $163
2020 $1,927 $708 $96–$2,890 $114
2021 $2,923 $1,213 $152–$3,994 $132
2022 $1,671 $1,230 $159–$3,998 $149
2023 $10,015 $584 $146–$2,836 $160
2024 $3,301 $628 $163–$3,168 $164
2025 $8,437 $664 $172–$3,055 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Arthrex, Inc. $26,117 107 payments
  2. Southern Edge Orthopaedics, Inc. $3,954 6 payments
  3. Stryker Corporation $3,888 27 payments
  4. Smith+Nephew, Inc. $2,860 22 payments
  5. Horizon Therapeutics plc $992 44 payments
  6. DePuy Synthes Sales Inc. $854 22 payments
  7. Miach Orthopaedics, Inc. $742 3 payments
  8. Innovation Technologies Inc $250 1 payment
  9. Bioventus LLC $184 2 payments
  10. Pacira Pharmaceuticals Incorporated $162 3 payments
  11. Other $1,131 33 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $12,100 4 payments
  2. Consulting Fee $10,000 3 payments
  3. Food and Beverage $8,985 228 payments
  4. Travel and Lodging $6,706 31 payments
  5. Education $3,344 4 payments
Products named General payments · program years 2019–2025
  1. CAPITAL CONSUMABLES CONSUMABLES RF BRF $4,516 2 payments
  2. ACCUPASS DIRECT Crescent XL $1,340 2 payments
  3. Hipstruments $1,274 6 payments
  4. HIP ARTHROSCOPY ACCESS & INSTRUMENTATION SET $1,008 5 payments
  5. SALVATION $923 9 payments
  6. Q-Fix $892 1 payment
  7. INSPACE $842 7 payments
  8. Regeneten $776 9 payments
  9. PENNSAID $652 37 payments
  10. ICONIX $618 2 payments
  11. Other $4,574 94 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 9 drugs

Part D claims

422

Median for Orthopedic Surgery: 203

Drug cost

$5,756

Median for Orthopedic Surgery: $1,433

Branded share of claims

4.3%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Celecoxib Generic 123 $3,273
Ibuprofen Generic 81 $809
Diclofenac Sodium Generic 28 $508
Cyclobenzaprine Hcl Generic 42 $395
Omeprazole Generic 37 $303
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 18 $206
Meloxicam Generic 70 $136
Methylprednisolone Generic 11 $66
Tramadol Hcl Generic 12 $60

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 39 billing codes

Paid by Medicare

$19,642

Medicare's payments for the services billed

Medicare patients

57

Average age 69

Services billed

203

31 women, 26 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 70%
High blood pressure 67%
Ischemic heart disease 32%
Diabetes 23%
Depression 21%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

1 product · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
Exparel
  • Pacira Pharmaceuticals Incorporated $10
$10 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

270 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Sports Medicine in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record